227 related articles for article (PubMed ID: 20860995)
21. Diagnosing Invasive Candidiasis.
Clancy CJ; Nguyen MH
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29444828
[TBL] [Abstract][Full Text] [Related]
22. Problematic Dichotomization of Risk for Intensive Care Unit (ICU)-Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients.
Playford EG; Lipman J; Jones M; Lau AF; Kabir M; Chen SC; Marriott DJ; Seppelt I; Gottlieb T; Cheung W; Iredell JR; McBryde ES; Sorrell TC
Clin Infect Dis; 2016 Dec; 63(11):1463-1469. PubMed ID: 27601224
[TBL] [Abstract][Full Text] [Related]
23. [Detection of anti-Candida antibodies of the classes IgM, IgG and IgA using enzyme immunoassay in sequential serum samples of hospitalized patients].
Werle E; Kappe R; Fiehn W; Sonntag HG
Mycoses; 1994; 37 Suppl 1():71-8. PubMed ID: 7854370
[TBL] [Abstract][Full Text] [Related]
24. Clinical value of (1,3)-β-D-glucan, mannan, antimannan IgG and IgM antibodies in diagnosis of invasive candidiasis.
Li F; Yu X; Ye L; Zhou G; Wang L; Luo Y
Med Mycol; 2019 Nov; 57(8):976-986. PubMed ID: 30820536
[TBL] [Abstract][Full Text] [Related]
25. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia.
Mikulska M; Calandra T; Sanguinetti M; Poulain D; Viscoli C;
Crit Care; 2010; 14(6):R222. PubMed ID: 21143834
[TBL] [Abstract][Full Text] [Related]
26. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study.
León C; Ruiz-Santana S; Saavedra P; Galván B; Blanco A; Castro C; Balasini C; Utande-Vázquez A; González de Molina FJ; Blasco-Navalproto MA; López MJ; Charles PE; Martín E; Hernández-Viera MA;
Crit Care Med; 2009 May; 37(5):1624-33. PubMed ID: 19325481
[TBL] [Abstract][Full Text] [Related]
28. [Detection and analysis of serum level of anti-Candida enolase IgG antibody in patients with autoimmune diseases].
He Z; Wang T; Shan D; Zhang X; Wang G; Wang F
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Aug; 33(8):1113-1117. PubMed ID: 28871953
[TBL] [Abstract][Full Text] [Related]
29. Prospective evaluation of lymphocyte subtyping for the diagnosis of invasive candidiasis in non-neutropenic critically ill patients.
Zhang J; Cui N; Long Y; Wang H; Han W; Li Y; Xiao M
Int J Infect Dis; 2019 Jan; 78():140-147. PubMed ID: 30399447
[TBL] [Abstract][Full Text] [Related]
30. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
Pini P; Colombari B; Marchi E; Castagnoli A; Venturelli C; Sarti M; Blasi E
Diagn Microbiol Infect Dis; 2019 Jan; 93(1):39-43. PubMed ID: 30098849
[No Abstract] [Full Text] [Related]
31. Diagnostic value of Candida mannan antigen and anti-mannan IgG and IgM antibodies for Candida infection.
Wang K; Luo Y; Zhang W; Xie S; Yan P; Liu Y; Li Y; Ma X; Xiao K; Fu H; Cai J; Xie L
Mycoses; 2020 Feb; 63(2):181-188. PubMed ID: 31755600
[TBL] [Abstract][Full Text] [Related]
32. Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy.
Lunel FM; Donnelly JP; van der Lee HA; Blijlevens NM; Verweij PE
Med Mycol; 2011 Nov; 49(8):848-55. PubMed ID: 21619440
[TBL] [Abstract][Full Text] [Related]
33. Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever.
Ellis M; Al-Ramadi B; Bernsen R; Kristensen J; Alizadeh H; Hedstrom U
J Med Microbiol; 2009 May; 58(Pt 5):606-615. PubMed ID: 19369522
[TBL] [Abstract][Full Text] [Related]
34. Proteomic profiling of serologic response to Candida albicans during host-commensal and host-pathogen interactions.
Pitarch A; Nombela C; Gil C
Methods Mol Biol; 2009; 470():369-411. PubMed ID: 19089396
[TBL] [Abstract][Full Text] [Related]
35. A Murine, Bispecific Monoclonal Antibody Simultaneously Recognizing β-Glucan and MP65 Determinants in Candida Species.
Zito A; Bromuro C; Mandili G; Chiani P; Horenstein AL; Malavasi F; Cauda R; Cassone A; Torosantucci A
PLoS One; 2016; 11(2):e0148714. PubMed ID: 26859561
[TBL] [Abstract][Full Text] [Related]
36. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
Pazos C; Moragues MD; Quindós G; Pontón J; del Palacio A
Rev Iberoam Micol; 2006 Dec; 23(4):209-15. PubMed ID: 17388644
[TBL] [Abstract][Full Text] [Related]
38. [Value of the detection of anti-Candida antibodies and IgM isotypes in the diagnosis of deep Candida infections].
Eloy O; Kerfant M; Pina P; Allouch PY; Pangon BH; Ghnassia JC
Ann Biol Clin (Paris); 2001; 59(1):79-83. PubMed ID: 11174105
[No Abstract] [Full Text] [Related]
39. Anti-Candida antibodies in serum and saliva of patients with denture stomatitis.
Kantardjiev TV; Popova EV
Folia Med (Plovdiv); 2002; 44(4):39-44. PubMed ID: 12751686
[TBL] [Abstract][Full Text] [Related]
40. Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis.
Kondori N; Edebo L; Mattsby-Baltzer I
Clin Diagn Lab Immunol; 2004 Mar; 11(2):344-50. PubMed ID: 15013986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
